Susquehanna International Group
BJDX icon

Susquehanna International Group’s Bluejay Diagnostics BJDX Stock Holding History

Susquehanna International Group’s Portfolio BJDX Stock Details BJDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3
Closed -$28.5K – 12574
2022
Q4 		$28.5K Buy
+3
New +$65K ﹤0.01% 11639

Other funds holding BJDX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Susquehanna International Group's BJDX Position: Q1 2023 in Review

Susquehanna International Group sold out of Bluejay Diagnostics (BJDX) in Q1 2023, closing a stake of 3 shares — an estimated $28.5K sold.

Susquehanna International Group first reported a position in BJDX in Q4 2022 and held it in 1 quarter. The position peaked at $28.5K in Q4 2022. 2 funds tracked by Wall St. Rank hold BJDX as of Q1 2023.

  • Susquehanna International Group reported no remaining Bluejay Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Susquehanna International Group sold 3 Bluejay Diagnostics shares in Q1 2023, an estimated $28.5K.
  • Susquehanna International Group first reported a position in Bluejay Diagnostics in Q4 2022 and held it in 1 quarter.
  • Susquehanna International Group's Bluejay Diagnostics position peaked at $28.5K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Bluejay Diagnostics as of Q1 2023.

Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.